Search

everythinglearnresearchcommunity

for

Search:↓

EGFR helps mouse hair follicles stop growing by reducing certain growth regulators.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

EGFR inhibitors often cause dry, brittle hair and eyebrow/eyelash changes.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Different forms of the Vitamin D receptor can impact metabolic and hormone issues in Polycystic Ovary Syndrome.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

Lasers can help reduce skin side effects from cancer treatment.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Estrogen affects hair growth, and GPER-1 levels might help identify hair loss types.

GLP-1 agonists may increase the risk of hair loss.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Gefitinib can cause scalp skin issues and permanent hair loss.